Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
Clinical trial NCT02683239 · COMPLETED
Trial details
- NCT number
- NCT02683239
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-17
- Primary completion
- 2020-12-01
- Enrollment
- 5331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.